Antibiotic Resistance of Urinary Tract Infection Recurrences in a Large Integrated US Healthcare System
The Journal of Infectious Diseases · 16.12.2024 · 230 (6) · e1344-e1354
DOI: 10.1093/infdis/jiae233 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 14.05.2024. Verfasst von Jennifer H Ku und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Evaluation, Kaiser Permanente Southern California. Hauptthemen laut MEDLINE: Urinary Tract Infections, Anti-Bacterial Agents, Recurrence. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GlaxoSmithKline.
Abstract (Originalsprache)
Background
Data on antibiotic resistance of uropathogens for urinary tract infection (UTI) recurrences are lacking.
Methods
In a retrospective cohort of adults at Kaiser Permanente Southern California with culture-confirmed index uncomplicated UTI (uUTI) between January 2016 and December 2020, we examined the number and characteristics of subsequent culture-confirmed UTIs through 2021.
Results
We identified 148 994 individuals with a culture-confirmed index uUTI (88% female, 44% Hispanic; mean age, 51 years [standard deviation, 19 years]), of whom 19% developed a subsequent culture-confirmed UTI after a median 300 days (interquartile range, 126–627 days). The proportion of UTI due to Escherichia coli was highest for index uUTI (79%) and decreased to 73% for sixth UTI (UTI 6) (P for trend < .001), while the proportion due to Klebsiella spp increased from index UTI (7%) to UTI 6 (11%) (P for trend < .001). Nonsusceptibility to ≥1 and ≥3 antibiotic classes was observed in 57% and 13% of index uUTIs, respectively, and was higher for subsequent UTIs (65% and 20%, respectively, for UTI 6). Most commonly observed antibiotic nonsusceptibility patterns included penicillins alone (12%), and penicillins and trimethoprim-sulfamethoxazole plus ≥1 additional antibiotic class (9%).
Conclusions
Antibiotic nonsusceptibility is common in UTIs and increases with subsequent UTIs. Continuous monitoring of UTI recurrences and susceptibility patterns is needed to guide treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research and Evaluation, Kaiser Permanente Southern California.
- Kaiser Permanente Southern California and Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
- GlaxoSmithKline, Siena, Italy.
- Department of Epidemiology, University of Alabama at Birmingham.
ORCID-Profile: Jennifer H Ku, Sara Y Tartof, Katia J Bruxvoort
Förderung
- GlaxoSmithKline
Zitieren
APA
Ku, J. H., Tartof, S. Y., Contreras, R., Ackerson, B. K., Chen, L. H., Reyes, I. A. C., Pellegrini, M., Schmidt, J. E., & Bruxvoort, K. J. (2024). Antibiotic Resistance of Urinary Tract Infection Recurrences in a Large Integrated US Healthcare System. The Journal of Infectious Diseases, 230(6), e1344-e1354. https://doi.org/10.1093/infdis/jiae233
Vancouver
Ku JH, Tartof SY, Contreras R, Ackerson BK, Chen LH, Reyes IAC, et al. Antibiotic Resistance of Urinary Tract Infection Recurrences in a Large Integrated US Healthcare System. The Journal of Infectious Diseases. 2024;230(6):e1344-e1354. doi:10.1093/infdis/jiae233
BibTeX
@article{Ku2024,
author = {Ku, Jennifer H and Tartof, Sara Y and Contreras, Richard and Ackerson, Bradley K and Chen, Lie H and Reyes, Iris A C and Pellegrini, Michele and Schmidt, Johannes E and Bruxvoort, Katia J},
title = {Antibiotic Resistance of Urinary Tract Infection Recurrences in a Large Integrated US Healthcare System},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {230},
number = {6},
pages = {e1344--e1354},
doi = {10.1093/infdis/jiae233}
}
EUVIMED